Nutralife Biosciences Stock Current Liabilities
Nutralife Biosciences fundamentals help investors to digest information that contributes to Nutralife Biosciences' financial success or failures. It also enables traders to predict the movement of Nutralife Pink Sheet. The fundamental analysis module provides a way to measure Nutralife Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nutralife Biosciences pink sheet.
Nutralife |
Nutralife Biosciences Company Current Liabilities Analysis
Nutralife Biosciences' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Nutralife Biosciences has a Current Liabilities of 0.0. This is 100.0% lower than that of the Healthcare sector and about the same as Drug Manufacturers—Specialty & Generic (which currently averages 0.0) industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Price Transformation Now
Price TransformationUse Price Transformation models to analyze the depth of different equity instruments across global markets |
All Next | Launch Module |
Nutralife Fundamentals
Return On Equity | -14.26 | |||
Return On Asset | -0.28 | |||
Operating Margin | (3.80) % | |||
Current Valuation | 11.61 M | |||
Shares Outstanding | 176.62 M | |||
Shares Owned By Insiders | 45.95 % | |||
Price To Book | 85.51 X | |||
Price To Sales | 14.09 X | |||
Revenue | 626.62 K | |||
Gross Profit | 83.59 K | |||
EBITDA | (5.71 M) | |||
Net Income | (5.83 M) | |||
Cash And Equivalents | 51.8 K | |||
Total Debt | 10 K | |||
Current Ratio | 0.10 X | |||
Book Value Per Share | (0.01) X | |||
Cash Flow From Operations | (487.39 K) | |||
Earnings Per Share | (0.03) X | |||
Number Of Employees | 12 | |||
Beta | -0.9 | |||
Market Capitalization | 6.62 M | |||
Total Asset | 4.85 M | |||
Net Asset | 4.85 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Nutralife Pink Sheet
If you are still planning to invest in Nutralife Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nutralife Biosciences' history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Transaction History View history of all your transactions and understand their impact on performance | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |